There was no difference in the prevalence of MMR deficiency in the two groups however, the higher age at diagnosis in the BW group supported the view that MMR testing should be universal rather than focused on the younger EC population. The gene discussed is MRC1; the disease is mismatch repair cancer syndrome 1.